Luprova 11.25mg Injection

Luprova 11.25mg injection contains the active ingredient leuprolide acetate, a gonadotropin-releasing hormone (GnRH) agonist. It is indicated for treating prostate cancer in men, hormone-responsive breast cancer, endometriosis (tissue that normally lines the interior of the uterus growing outside it), and uterine fibroids (benign growths of the uterus) in women. The injection is also used to treat central precocious puberty, characterised by early physical development in children due to hormonal imbalances. Do not receive this injection if you are allergic to leuprolide acetate or any ingredients in Luprova 11.25mg. Inform your physician before receiving this medicine if you have liver or kidney impairment. Notify your doctor if you have undiagnosed abnormal uterine bleeding. This treatment is contraindicated in pregnancy or if you are planning to conceive. During treatment, existing symptoms may temporarily worsen due to increased sex steroid levels in the body; discuss this with your physician. Inform your doctor if your child has a progressive brain tumour. Before starting treatment, disclose underlying medical conditions including diabetes, seizures, cardiac problems with chest pain, irregular heartbeats, depression, or increased risk of bone density loss (osteoporosis). This medicine is not recommended for patients with abnormal vaginal bleeding. Women of childbearing age should use non-hormonal contraception during Luprova 11.25mg injection therapy. Inform your doctor if you are a man with urinary obstruction or have undergone testicular surgery. Report to your doctor if you experience spinal cord compression and develop urinary disorders or haematuria (blood in urine).

Prostate cancer Hormone-responsive breast cancer in perimenopausal (around menopause) women Endometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus) Central precocious puberty (a child’s body begins to change into an adult too soon caused by a release of certain hormones)

Luprova 11.25mg decreases testosterone or estrogen production, depending on the treated condition. This helps to slow the growth of cancer cells, reduce the size of uterine fibroids, and alleviate the symptoms of endometriosis and early onset of puberty.

Luprova 11.25mg injection is usually administered in the arm, thigh or abdomen. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious Severe rash, itching Shortness or difficulty of breath Cough with blood Pulmonary embolism Severe headache Common Altered blood sugar and cholesterol levels Injection site reactions Loss of appetite Abnormal liver function Swelling in the ankle or hand Difficulty sleeping, headache Mood swings, depression Weight changes Nausea, vomiting Vaginal dryness, bleeding Loss of interest in sexual intercourse Hot flushes Bone pain, muscle weakness Breast tenderness

During the treatment of breast cancer with Luprova 11.25mg, it is recommended to undergo regular checkups every three months in combination with an aromatase inhibitor. Do not receive this injection if you experience any abnormal vaginal bleeding. Consult your doctor immediately if you or your child is suffering from a headache even after treating it with pain killer, vision problems, buzzing, or ringing in the ear. If you have diabetes, ask your doctor to monitor your glucose and blood sugar levels regularly. Before starting, inform your doctor if you are still mensurating.